Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

Hancock says UK genome service is now ‘rolling out’

Hancock says UK genome service is now ‘rolling out’

The news was welcomed by Mike Thompson, chief executive of the Association of the British Pharma Industry (ABPI), who said: “The health secretary’s focus on earlier diagnosis and more personalised ... medicines for cancer and rare diseases is great

Latest news

  • Novartis cuts manufacturing jobs in Switzerland and UK Novartis cuts manufacturing jobs in Switzerland and UK

    Chief executive Vas Narasimhan says the cuts are part of Novartis’ strategy to move away from high-volume drug production towards more specialised and personalised medicines.

  • UK pharma to work with innovation network on NHS uptake UK pharma to work with innovation network on NHS uptake

    The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of  medicines and other 'biomedical innovations' ... These areas include economic growth, digital

  • GSK: we won’t be splitting up any time soon GSK: we won’t be splitting up any time soon

    prescription medicines businesses. ... GSK is investing $300m in the firm, and says a long-term partnership to exploit its genetic databases will help it advance personalised medicines research throughout its pipeline.

  • The shifting healthcare landscape The shifting healthcare landscape

    With more personalised medicines targeting specific patient groups, payers cannot apply the old funding approach but need to find new ways to reward innovation. ... Many of these future opportunities rely on companies stepping out of their corner as a

  • The state of trust The state of trust

    There is, however, a trust relationship between government and pharma regarding the production of medicines, but the big problem we have is that pharma doesn’t talk directly to patients. ... Healthy distrust. With the introduction of personalised

More from news
Approximately 13 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that? Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?

    In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... It follows that the next generation of relationship holders, representing very expensive but ultra-personalised medicines like CAR-Ts

  • Patently unclear? Patently unclear?

    Another example of such obstacles is the question of whether you can get patent protection for methods of diagnosing disease and for personalised medicine. ... It appears that the situation is still evolving and that for the time being getting patent

  • Real-world evidence Real-world evidence

    work to answer important clinical questions (which may have not been possible otherwise), and it can support the development of evidence-based personalised medicines through the linking of electronic medical records

  • Stronger together Stronger together

    Most recently the European Medicines Agency raised its expectations of pharmaceutical companies, calling for closer integration of patients' views when it issued new guidance last month on the use of ... As new medical technologies like stem cells and

  • It's behind you! It's behind you!

    The advent of smart contact lenses, wearable technologies and personalised medicines offer a tantalising glimpse into the future and how we may understand and assess the patient.

More from intelligence
Approximately 4 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Mastering the precision medicine opportunity

    Personalised: Developing and choosing medicines that will change the patient experience, from one of hope to one of certainty of response. ... In personalised medicine, we ask if we can use a particular treatment in a patient.

  • Medopad: the up and coming unicorn transforming remote patient monitoring

    The company has developed a platform for creating modular apps which can be personalised across numerous patient cohorts, using a combination of artificial intelligence, rich data analysis and a strong understanding ... Healthcare is becoming more precise

  • Medicines personalised for Tom, Dick and Harry

    And so enters the concept of personalised medicine with the aim of providing treatments to ever-shrinking populations of high responders. ... Perhaps more radical ideas need to be considered to deliver personalised medicine that is both equitable and

  • Being Human - The healthcare angle

    The industry is busily developing innovative, often personalised medicines, but we’re under unprecedented scrutiny.

  • Pragmatic Digital Health

    These will be manifest not just in the provision of individual diagnoses but in deeper insights into the use of personalised medicines, i.e.

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics